Dr. Peter Gallant is a serial entrepreneur with extensive experience in the global water technology sector. As the founding President and CEO of Kingston, Ontario-based Pathogen Detection Systems Inc. (PDS), he led the development of a novel automated microbial detection system. In 2009, PDS was acquired by Veolia Water Solutions and Technologies, a division of the world’s largest environmental services company – and became ENDETEC – the global water quality sensor platform for Veolia Water.
From 2009 until April, 2015, Dr. Gallant served as Vice President, Business Development and Regulatory Affairs of ENDETEC, notably leading the team that secured the first-ever US EPA approval for an automated microbiological testing system for regulatory compliance testing of drinking water samples under the Total Coliform Rule. Over his career he has founded and led a start-up in the software industry, has served in several advisory roles for government agencies and start-up companies, and he currently serves as co-Chair of the Steering Committee of the American Water Works Association’s committee on barriers to innovation in the water sector.
He has authored or co-authored numerous technical publications, is a co-inventor on several patents on innovative water quality sensor technologies, and is a frequent speaker at industry events worldwide.
Dr. Gallant is also an adjunct faculty member in the internationally ranked Queen’s School of Business, where he lectures on entrepreneurship, strategy, innovation and new venture finance at the undergraduate and MBA level. Dr. Gallant holds B.Sc., M.Sc. and Ph.D. degrees in Electrical and Computer Engineering from Queen’s University in Kingston, Ontario, Canada.
Prior to joining the WaterTAP management team, he served as a Director of WaterTAP from its inception until March 2015, including most recently a term as Vice Chair of the Board. Previously, he had been appointed by the Provincial Government to serve on the Ontario Council on University Affairs.Return to Team